PUBLICATION

Disruption of the glucagon receptor increases glucagon expression beyond α-cell hyperplasia in zebrafish

Authors
Kang, Q., Zheng, J., Jia, J., Xu, Y., Bai, X., Chen, X., Zhang, X.K., Wong, F.S., Zhang, C., Li, M.
ID
ZDB-PUB-221106-5
Date
2022
Source
The Journal of biological chemistry   298(12): 102665 (Journal)
Registered Authors
Li, Mingyu
Keywords
Glucagon, Glucagon Receptor, Pancreatic α cells, Single-cell sequencing, Zebrafish
Datasets
GEO:GSE179894
MeSH Terms
  • Animals
  • Glucagon*
  • Hyperplasia
  • RNA, Messenger
  • Receptors, Glucagon*/genetics
  • Receptors, Glucagon*/metabolism
  • Zebrafish/genetics
  • Zebrafish/metabolism
PubMed
36334626 Full text @ J. Biol. Chem.
Abstract
The glucagon receptor (GCGR) is a potential target for diabetes therapy. Several emerging GCGR antagonism-based therapies are under pre-clinical and clinical development. However, GCGR antagonism, as well as genetically-engineered GCGR deficiency in animal models is accompanied by α-cell hyperplasia and hyperglucagonemia, which may limit the application of GCGR antagonism. To better understand the physiological changes in α cells following GCGR disruption, we performed single cell sequencing of α cells isolated from control and gcgr-/- (glucagon receptor deficient) zebrafish. Interestingly, beyond the α-cell hyperplasia, we also found that the expression of gcga, gcgb, pnoca and several glucagon-regulatory transcription factors were dramatically increased in one cluster of gcgr-/- α cells. We further confirmed that glucagon mRNA was upregulated in gcgr-/- animals by in situ hybridization, and that glucagon promoter activity was increased in gcgr-/-;Tg(gcga:GFP) reporter zebrafish. We also demonstrated that gcgr-/- α cells had increased glucagon protein levels, and increased granules after GCGR disruption. Intriguingly, the increased mRNA and protein levels could be suppressed by treatment with high-level glucose or knockdown of the pnoca gene. In conclusion, these data demonstrated that GCGR-deficiency not only induced α-cell hyperplasia but also increased glucagon expression in α cells, findings which provide more information about physiological changes in α-cells when the GCGR is disrupted.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping